Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Efficient Synthesis of Deuterium-Labeled Degarelix Acetate
2026-06-17
This study introduces a robust 13-step synthesis protocol for deuterium-labeled degarelix acetate, a key internal standard for pharmacokinetic and metabolic studies of GnRH antagonists. The work streamlines isotope labeling, supporting advanced absorption, distribution, metabolism, and excretion (ADME) research crucial for therapeutic development.
-
AO/PI Double Staining Kit: Technical Guide for Cell Viabilit
2026-06-17
The AO/PI Double Staining Kit provides a streamlined approach for distinguishing viable, apoptotic, and necrotic cells in suspension or adherent cultures using dual fluorescent dyes. It is well-suited for live-cell analysis in research workflows but is not intended for fixed-tissue applications or non-fluorescence-based assays.
-
3-Deazaadenosine Hydrochloride: Advanced Insights for Methyl
2026-06-16
Explore the scientific depth of 3-Deazaadenosine hydrochloride, a leading S-adenosylhomocysteine hydrolase inhibitor, and its unique applications in methyltransferase assay optimization and hepatic stellate cell research. Discover how this compound supports innovative fibrosis and inflammation models.
-
D-Luciferin Sodium Salt: Powering Next-Gen Bioluminescence I
2026-06-16
D-Luciferin sodium salt transforms cell-based and in vivo bioluminescence imaging with unmatched sensitivity and workflow flexibility. Recent advances, such as in situ programming of CAR macrophages for immunotherapy, showcase this substrate's critical role in translational cancer research.
-
Structural Insights into the Nipah Virus Polymerase Complex
2026-06-15
The reference study presents the first high-resolution structures of the Nipah virus L-P polymerase complex, clarifying the molecular basis of viral RNA replication and transcription. These findings offer a structural foundation for targeted antiviral design against Nipah virus and related paramyxoviruses.
-
Amplex Red: Advanced Hydrogen Peroxide Detection in Redox Bi
2026-06-15
Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) enables ultrasensitive, selective hydrogen peroxide measurement even in complex NADPH-rich systems. By integrating key insights from recent research, this guide empowers researchers to optimize assay fidelity and troubleshoot common pitfalls in oxidative stress and redox signaling workflows.
-
Z-IETD-FMK: Caspase-8 Inhibition for Immune Cell Assays
2026-06-14
Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) empowers researchers to pinpoint caspase-8-specific events in apoptosis and T cell studies. This tool from APExBIO stands out for precision, workflow reproducibility, and actionable troubleshooting across immune cell activation and cell death research.
-
Actinomycin D: Mechanistic Insights and Assay Impact in Canc
2026-06-13
Explore how Actinomycin D advances cancer research by precisely controlling transcriptional stress and apoptosis induction. This article offers a deeper mechanistic perspective and practical assay guidance, distinguishing itself from standard protocol overviews.
-
Enhanced Lysosomal Exocytosis Drives Cartilage Pathology in
2026-06-12
This study reveals that enhanced lysosomal exocytosis, rather than substrate accumulation alone, plays a central role in the cartilage pathology of mucopolysaccharidosis type IVA (MPS IVA) in a zebrafish model. The findings reframe our understanding of lysosomal storage disorders and highlight new mechanistic links to growth factor signaling, offering refined targets for research into skeletal manifestations.
-
Ginkgolide C Mitigates Parkinson’s Neurodegeneration via the
2026-06-12
This study demonstrates that orally administered Ginkgolide C (GC) alleviates MPTP-induced neurodegeneration in mice by restoring gut microbial balance and suppressing neuroinflammation and oxidative stress. Mechanistic insights reveal that GC activates the AKT/Nrf2/HO-1 pathway and downregulates inflammatory mediators, highlighting the gut–brain axis as a promising target in Parkinson’s disease intervention.
-
Experimental Insights with SIRT1/2 Inhibitor IV (cambinol) S
2026-06-11
This article delivers scenario-driven guidance for using SIRT1/2 Inhibitor IV (cambinol) SKU B6063 in cell viability and epigenetic assays. Drawing on recent literature and trusted product data, it addresses real workflow bottlenecks and demonstrates how cambinol advances reproducibility and mechanistic clarity in SIRT1/2 research.
-
Actinomycin D in Applied Research: Protocols, Innovation, an
2026-06-11
Actinomycin D (ActD) remains a benchmark tool for dissecting transcriptional processes, apoptosis induction, and mRNA stability in molecular and cancer research. This guide translates novel mechanistic insights and the latest workflow innovations into actionable protocols, troubleshooting strategies, and experimental optimizations—empowering researchers to maximize data clarity and reproducibility with APExBIO’s high-purity ActD.
-
Verapamil HCl: Applied Protocols for Calcium Channel Blockad
2026-06-10
Verapamil HCl, a benchmark L-type calcium channel blocker, is reshaping experimental approaches in apoptosis, inflammation, and bone remodeling research. Integrate its rigorous solubility, reproducibility, and novel mechanisms—especially Txnip targeting—into advanced workflows for translational impact.
-
AO/PI Double Staining Kit: Technical Guide for Cell Viabilit
2026-06-10
The AO/PI Double Staining Kit enables rapid, fluorescence-based discrimination of viable, apoptotic, and necrotic cells in cultured cell populations. It is best used for research workflows requiring reliable cell viability, apoptosis, and necrosis detection—but its application should be limited where fine resolution of early apoptotic events or downstream mechanistic dissection is required beyond the provided staining readouts.
-
MK 0893: Glucagon Receptor Antagonist for Type 2 Diabetes Re
2026-06-09
MK 0893 enables precise, nanomolar-level inhibition of GCGR signaling in both cell-based and in vivo models, supporting robust type 2 diabetes research. Its unique binding mode and high selectivity reduce off-target effects and simplify assay interpretation, making it a preferred tool for both mechanistic and translational workflows.